AVA Investment Analytics (AVAIA) is the public markets division of Apex Venture Advisors, LLC.
AVAIA is overseen by Mike Stathis, our Chief Investment Strategist. AVAIA is a results-driven research and publishing firm focusing on serving institutional investors. Research leading to the formation of AVAIA began in 2003 although the company did not form officially until 2005. Due to high demand for our services, we are now expanding our geographic client base with the 2009 launch of this site.
We have worked with the following types of clients:
- Corporate Treasury Departments
- Pension Funds
- Financial Institutions
- Hedge Funds
- Private Equity Firms
- Venture Capital Firms
- Mutual Funds
- Family Investment Offices
- High-Net Worth Investors
About Mike Stathis
Mike is the Principal and Chief Investment Strategist of AVA Investment Analytics. He oversees all investment consultations to institutional investors. He is also the Managing Principal of Apex Venture Advisors, the parent company of AVAIA.
Mike previously worked for UBS and Bear Stearns in asset management and merchant banking. where he dealt with institutional investors, including corporate treasury departments and pension funds. He was the only professional in private client services at Bear Stearns to also hold a position in the biotechnology merchant banking department. He has personally managed hundreds of investment accounts, served as an adviser to venture capital firms, and worked with numerous entrepreneurs.
As the only expert who predicted the financial apocalypse in detail, Mike has been a valuable source of guidance for investors, helping them to navigate the real estate and banking crisis, as well as the resulting global economic collapse. The accuracy of his predictions has positioned him as one of America’s most insightful and creative financial experts. He is the author of America’s Healthcare Solution, The Wall Street Investment Bible, America’s Financial Apocalypse, Cashing in on the Real Estate Bubble and The Startup Company Bible for Entrepreneurs.
Prior to his work at UBS and Bear Stearns, Mike completed more than 800 college credit hours in the sciences, including countless graduate level courses in chemistry, physics, biochemistry, immunology, physiology, pathology, and so forth. He holds a Masters of Science in biophysics and biological chemistry and a minor in mathematics, and was a National Science Foundation Research Fellow where he performed research in solid state physics. He has also performed chemistry research in oil, as well as alternative energy (theoretical aspects of solar and hydrogen fuel).
He also taught a course which he designed himself on biotechnology at Southern Methodist University.
His investment expertise spans several industries, but his technology focus in both the public and private markets is healthcare (including healthcare IT) and biopharma.
Internships and Employment
Please see here for information about internships and employment opportunities